Oklahoma: Belviq (lorcaserin) litigation | DrugsMonitor.com

Belviq (lorcaserin) litigation in Oklahoma (OK): MDL-linked practice notes, filing-deadline context, confidential review—not legal advice.

lorcaserin, weight management drug, market withdrawal, cancer signal studies, Oklahoma